{"id":82805,"date":"2018-06-15T06:15:46","date_gmt":"2018-06-15T06:15:46","guid":{"rendered":"http:\/\/www.bnreport.com\/reduce-sun-pharma-target-rs-482-elara-capital\/"},"modified":"2018-06-15T06:15:46","modified_gmt":"2018-06-15T06:15:46","slug":"reduce-sun-pharma-target-rs-482-elara-capital","status":"publish","type":"post","link":"https:\/\/www.bnreport.com\/en\/reduce-sun-pharma-target-rs-482-elara-capital\/","title":{"rendered":"Reduce  Sun Pharma, target Rs  482:   Elara Capital"},"content":{"rendered":"<ul>\n<li>Digg<\/li>\n<li>Google Bookmarks<\/li>\n<li>StumbleUpon<\/li>\n<li>Reddit<\/li>\n<li>Newsvine<\/li>\n<li>Live Bookmarks<\/li>\n<li>Technorati<\/li>\n<li>Yahoo Bookmarks<\/li>\n<li>Blogmarks<\/li>\n<li>Del.icio.us<\/li>\n<li>ApnaCircle<\/li>\n<li>Google Plus<\/li>\n<li>Pinterest<\/li>\n<\/ul>\n<p>ETMarkets.com|<\/p>\n<p>Updated: Jun 15, 2018, 10.20 AM IST<\/p>\n<figure><figcaption>Elara Capital has a reduce call on Sun Pharmaceutical Industries Ltd. with a target price of Rs 482.<\/figcaption><\/figure>\n<h2>Company Summary<\/h2>\n<p>ADD TO PORTFOLIO<\/p>\n<p>ADD TO WATCHLIST<\/p>\n<p>SHARE YOUR OULOOK<\/p>\n<p>ChartsValuation &amp; Peer ComparisonCommunity Buzz<\/p>\n<p><a href=\"https:\/\/economictimes.indiatimes.com\/topic\/Elara-Capital\" rel=\"noreferrer\" target=\"_blank\">Elara Capital<\/a> has a reduce call on <a href=\"https:\/\/economictimes.indiatimes.com\/sun-pharmaceutical-industries-ltd\/stocks\/companyid-9134.cms\" rel=\"noreferrer\" target=\"_blank\">Sun Pharmaceutical Industries Ltd.<\/a> with a target price of Rs 482 . The current market price of Sun Pharmaceutical Industries Ltd. is Rs 569.25 Time period given by the brokerage is a year when Sun Pharmaceutical Industries Ltd. price can reach defined target. .  <\/p>\n<p>Sun Pharmaceutical Industries Ltd., incorporated in 1993, is a largecap company with a market cap of Rs 134278.20 crore. <\/p>\n<p>Investment rationale by Elara Capital <\/p>\n<p>Halol clearance provides comfort on Suns achievement of guidance of early double-digit revenue growth in FY19. Focus would shift back to earnings quality and ramp-up in the specialty business. The stock has seen a 10% run-up over past three trading days post FDA status of VAI on the Halol facility. At the CMP, the stock is trading at rich valuations of 25x FY20E P\/E and factors in the Halol clearance, in our view. We retain Reduce with a TP of INR 482 based on 22x FY20E P\/E. <\/p>\n<p>Read this article in :<a href=\"https:\/\/economictimes.indiatimes.com\/hindi\/markets\/sujhav\/reduce-sun-pharma-target-rs-482-elara-capital\/articleshow\/64596703.cms\" rel=\"noreferrer\" target=\"_blank\">Hindi<\/a>Read more on<\/p>\n<h3>Also Read<\/h3>\n<p><a href=\"https:\/\/economictimes.indiatimes.com\/markets\/stocks\/recos\/reduce-cesc-target-rs-970-elara-capital\/articleshow\/64349266.cms\" rel=\"noreferrer\" target=\"_blank\">Reduce CESC, target Rs 970: Elara Capital<\/a><\/p>\n<p><a href=\"https:\/\/economictimes.indiatimes.com\/markets\/stocks\/recos\/accumulate-cyient-ltd-target-rs-900-0-elara-capital\/articleshow\/64089396.cms\" rel=\"noreferrer\" target=\"_blank\">Accumulate Cyient, target Rs 900: Elara Capital<\/a><\/p>\n<p><a href=\"https:\/\/economictimes.indiatimes.com\/markets\/stocks\/recos\/accumulate-tata-motors-target-rs-362-elara-capital\/articleshow\/64349587.cms\" rel=\"noreferrer\" target=\"_blank\">Accumulate Tata Motors, target Rs 362: Elara Capital<\/a><\/p>\n<p><a href=\"https:\/\/economictimes.indiatimes.com\/markets\/stocks\/recos\/accumulate-abb-india-target-rs-1390-elara-capital\/articleshow\/64154205.cms\" rel=\"noreferrer\" target=\"_blank\">Accumulate ABB India, target Rs 1390: Elara Capital<\/a><\/p>\n<p><a href=\"https:\/\/economictimes.indiatimes.com\/markets\/expert-view\/3-it-stocks-ravi-menon-of-elara-capital-is-bullish-on\/articleshow\/62251068.cms\" rel=\"noreferrer\" target=\"_blank\">3 IT stocks Ravi Menon of Elara Capital is bullish on<\/a><\/p>\n<p>Commenting feature is disabled in your country\/region.<\/p>\n<p>Disclaimer: This recommendation is analyst&#039;s own and does not represent those of economictimes.com &amp; ETMarkets.com. Please consult your financial advisor before taking any position in the stock\/s mentioned.<\/p>\n<h2>From  Around The Web<\/h2>\n<h2>More from The Economic Times<\/h2>\n<p><strong><a href=\"https:\/\/blockads.fivefilters.org\/\" rel=\"noreferrer\" target=\"_blank\"><\/a><\/strong> <a href=\"https:\/\/blockads.fivefilters.org\/acceptable.html\" rel=\"noreferrer\" target=\"_blank\"><\/a><\/p>\n<p><a href=\"https:\/\/economictimes.indiatimes.com\/markets\/stocks\/recos\/reduce-sun-pharma-target-rs-482-elara-capital\/articleshow\/64596702.cms\" rel=\"noreferrer\" target=\"_blank\">Original Article<\/a><\/p>\n<p>[contf]<br \/>\n[contfnew]<br \/>\n        <img decoding=\"async\" src=\"https:\/\/img.etimg.com\/photo\/60278104.cms\"\/><\/p>\n<h5><a href=\"https:\/\/economictimes.indiatimes.com\/\" rel=\"noreferrer\" target=\"_blank\">ET Markets<\/a><\/h5>\n<p>[contfnewc]<br \/>\n[contfnewc]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Digg<br \/>\nGoogle Bookmarks<br \/>\nStumbleUpon<br \/>\nReddit<br \/>\nNewsvine<br \/>\nLive Bookm..<\/p>\n","protected":false},"author":1,"featured_media":82806,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[202],"tags":[],"class_list":["post-82805","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finance"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Reduce Sun Pharma, target Rs 482:  Elara Capital - Business News Report<\/title>\n<meta name=\"description\" content=\"Digg Google Bookmarks StumbleUpon Reddit Newsvine Live Bookm..\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.bnreport.com\/en\/reduce-sun-pharma-target-rs-482-elara-capital\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Reduce Sun Pharma, target Rs 482:  Elara Capital - Business News Report\" \/>\n<meta property=\"og:description\" content=\"Digg Google Bookmarks StumbleUpon Reddit Newsvine Live Bookm..\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.bnreport.com\/en\/reduce-sun-pharma-target-rs-482-elara-capital\/\" \/>\n<meta property=\"og:site_name\" content=\"Business News Report\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Business-NewsReport-328225811095934\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-06-15T06:15:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.bnreport.com\/wp-content\/uploads\/2018\/06\/buysell8.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"210\" \/>\n\t<meta property=\"og:image:height\" content=\"158\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"infopal11\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@BNReport\" \/>\n<meta name=\"twitter:site\" content=\"@BNReport\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"infopal11\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/reduce-sun-pharma-target-rs-482-elara-capital\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/reduce-sun-pharma-target-rs-482-elara-capital\\\/\"},\"author\":{\"name\":\"infopal11\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#\\\/schema\\\/person\\\/19d1c5a2dd7f60584a09de4a7805d68f\"},\"headline\":\"Reduce Sun Pharma, target Rs 482: Elara Capital\",\"datePublished\":\"2018-06-15T06:15:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/reduce-sun-pharma-target-rs-482-elara-capital\\\/\"},\"wordCount\":325,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/reduce-sun-pharma-target-rs-482-elara-capital\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2018\\\/06\\\/buysell8.jpg\",\"articleSection\":[\"Finance\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.bnreport.com\\\/en\\\/reduce-sun-pharma-target-rs-482-elara-capital\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/reduce-sun-pharma-target-rs-482-elara-capital\\\/\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/reduce-sun-pharma-target-rs-482-elara-capital\\\/\",\"name\":\"Reduce Sun Pharma, target Rs 482: Elara Capital - Business News Report\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/reduce-sun-pharma-target-rs-482-elara-capital\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/reduce-sun-pharma-target-rs-482-elara-capital\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2018\\\/06\\\/buysell8.jpg\",\"datePublished\":\"2018-06-15T06:15:46+00:00\",\"description\":\"Digg Google Bookmarks StumbleUpon Reddit Newsvine Live Bookm..\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/reduce-sun-pharma-target-rs-482-elara-capital\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.bnreport.com\\\/en\\\/reduce-sun-pharma-target-rs-482-elara-capital\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/reduce-sun-pharma-target-rs-482-elara-capital\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2018\\\/06\\\/buysell8.jpg\",\"contentUrl\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2018\\\/06\\\/buysell8.jpg\",\"width\":210,\"height\":158},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/reduce-sun-pharma-target-rs-482-elara-capital\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629\",\"item\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Reduce Sun Pharma, target Rs 482: Elara Capital\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/\",\"name\":\"Business News Report\",\"description\":\"Latest News on the World of Politics &amp; Business\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#organization\",\"name\":\"\u0628\u0632\u0646\u0633 \u0631\u064a\u0628\u0648\u0631\u062a \u0627\u0644\u0627\u062e\u0628\u0627\u0631\u064a\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/LOGO2.png\",\"contentUrl\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/LOGO2.png\",\"width\":200,\"height\":50,\"caption\":\"\u0628\u0632\u0646\u0633 \u0631\u064a\u0628\u0648\u0631\u062a \u0627\u0644\u0627\u062e\u0628\u0627\u0631\u064a\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Business-NewsReport-328225811095934\\\/\",\"https:\\\/\\\/x.com\\\/BNReport\",\"https:\\\/\\\/www.instagram.com\\\/business.newsreport\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#\\\/schema\\\/person\\\/19d1c5a2dd7f60584a09de4a7805d68f\",\"name\":\"infopal11\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/author\\\/infopal11\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Reduce Sun Pharma, target Rs 482:  Elara Capital - Business News Report","description":"Digg Google Bookmarks StumbleUpon Reddit Newsvine Live Bookm..","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.bnreport.com\/en\/reduce-sun-pharma-target-rs-482-elara-capital\/","og_locale":"en_US","og_type":"article","og_title":"Reduce Sun Pharma, target Rs 482:  Elara Capital - Business News Report","og_description":"Digg Google Bookmarks StumbleUpon Reddit Newsvine Live Bookm..","og_url":"https:\/\/www.bnreport.com\/en\/reduce-sun-pharma-target-rs-482-elara-capital\/","og_site_name":"Business News Report","article_publisher":"https:\/\/www.facebook.com\/Business-NewsReport-328225811095934\/","article_published_time":"2018-06-15T06:15:46+00:00","og_image":[{"width":210,"height":158,"url":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2018\/06\/buysell8.jpg","type":"image\/jpeg"}],"author":"infopal11","twitter_card":"summary_large_image","twitter_creator":"@BNReport","twitter_site":"@BNReport","twitter_misc":{"Written by":"infopal11","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.bnreport.com\/en\/reduce-sun-pharma-target-rs-482-elara-capital\/#article","isPartOf":{"@id":"https:\/\/www.bnreport.com\/en\/reduce-sun-pharma-target-rs-482-elara-capital\/"},"author":{"name":"infopal11","@id":"https:\/\/www.bnreport.com\/en\/#\/schema\/person\/19d1c5a2dd7f60584a09de4a7805d68f"},"headline":"Reduce Sun Pharma, target Rs 482: Elara Capital","datePublished":"2018-06-15T06:15:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.bnreport.com\/en\/reduce-sun-pharma-target-rs-482-elara-capital\/"},"wordCount":325,"commentCount":0,"publisher":{"@id":"https:\/\/www.bnreport.com\/en\/#organization"},"image":{"@id":"https:\/\/www.bnreport.com\/en\/reduce-sun-pharma-target-rs-482-elara-capital\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2018\/06\/buysell8.jpg","articleSection":["Finance"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.bnreport.com\/en\/reduce-sun-pharma-target-rs-482-elara-capital\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.bnreport.com\/en\/reduce-sun-pharma-target-rs-482-elara-capital\/","url":"https:\/\/www.bnreport.com\/en\/reduce-sun-pharma-target-rs-482-elara-capital\/","name":"Reduce Sun Pharma, target Rs 482: Elara Capital - Business News Report","isPartOf":{"@id":"https:\/\/www.bnreport.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.bnreport.com\/en\/reduce-sun-pharma-target-rs-482-elara-capital\/#primaryimage"},"image":{"@id":"https:\/\/www.bnreport.com\/en\/reduce-sun-pharma-target-rs-482-elara-capital\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2018\/06\/buysell8.jpg","datePublished":"2018-06-15T06:15:46+00:00","description":"Digg Google Bookmarks StumbleUpon Reddit Newsvine Live Bookm..","breadcrumb":{"@id":"https:\/\/www.bnreport.com\/en\/reduce-sun-pharma-target-rs-482-elara-capital\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.bnreport.com\/en\/reduce-sun-pharma-target-rs-482-elara-capital\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.bnreport.com\/en\/reduce-sun-pharma-target-rs-482-elara-capital\/#primaryimage","url":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2018\/06\/buysell8.jpg","contentUrl":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2018\/06\/buysell8.jpg","width":210,"height":158},{"@type":"BreadcrumbList","@id":"https:\/\/www.bnreport.com\/en\/reduce-sun-pharma-target-rs-482-elara-capital\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629","item":"https:\/\/www.bnreport.com\/en\/"},{"@type":"ListItem","position":2,"name":"Reduce Sun Pharma, target Rs 482: Elara Capital"}]},{"@type":"WebSite","@id":"https:\/\/www.bnreport.com\/en\/#website","url":"https:\/\/www.bnreport.com\/en\/","name":"Business News Report","description":"Latest News on the World of Politics &amp; Business","publisher":{"@id":"https:\/\/www.bnreport.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.bnreport.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.bnreport.com\/en\/#organization","name":"\u0628\u0632\u0646\u0633 \u0631\u064a\u0628\u0648\u0631\u062a \u0627\u0644\u0627\u062e\u0628\u0627\u0631\u064a","url":"https:\/\/www.bnreport.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.bnreport.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/12\/LOGO2.png","contentUrl":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/12\/LOGO2.png","width":200,"height":50,"caption":"\u0628\u0632\u0646\u0633 \u0631\u064a\u0628\u0648\u0631\u062a \u0627\u0644\u0627\u062e\u0628\u0627\u0631\u064a"},"image":{"@id":"https:\/\/www.bnreport.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Business-NewsReport-328225811095934\/","https:\/\/x.com\/BNReport","https:\/\/www.instagram.com\/business.newsreport"]},{"@type":"Person","@id":"https:\/\/www.bnreport.com\/en\/#\/schema\/person\/19d1c5a2dd7f60584a09de4a7805d68f","name":"infopal11","url":"https:\/\/www.bnreport.com\/en\/author\/infopal11\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/posts\/82805","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/comments?post=82805"}],"version-history":[{"count":0,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/posts\/82805\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/media\/82806"}],"wp:attachment":[{"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/media?parent=82805"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/categories?post=82805"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/tags?post=82805"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}